North America Brain Implants Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Brain Implants Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Brain Implants Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising cases of neurological disorders
5.1.2 Technological advancements in implant materials

5.2 Market Opportunities

5.2.1 Growth in neurological disorder treatments
5.2.2 Advancements in brain implant technology

5.3 Future Trends

5.3.1 Growth in brain implants for neurological conditions
5.3.2 Rise in brain-machine interface technology

5.4 Impact of Drivers and Restraints

6. North America Brain Implants Market Regional Analysis

6.1 North America Brain Implants Market Overview

6.2 North America Brain Implants Market Revenue 2020-2030 (US$ Million)

6.3 North America Brain Implants Market Forecast Analysis

7. North America Brain Implants Market Analysis – by Treatment

7.1 Deep Brain Stimulation

7.1.1 Overview
7.1.2 Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Spinal Cord Stimulation

7.2.1 Overview
7.2.2 Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Vagus Nerve Stimulator

7.3.1 Overview
7.3.2 Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Invasive and Non-Invasive Brain-Computer Interface

7.4.1 Overview
7.4.2 Invasive and Non-Invasive Brain-Computer Interface: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Responsive Neurostimulation for Seizures

7.5.1 Overview
7.5.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Auditory Brainstem Implant

7.6.1 Overview
7.6.2 Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Ophthalmic Aid/Implant

7.7.1 Overview
7.7.2 Ophthalmic Aid/Implant: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Brain Implants Market Analysis – by Application

8.1 Chronic Pain

8.1.1 Overview
8.1.2 Chronic Pain: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Parkinson\'s Disease

8.2.1 Overview
8.2.2 Parkinson\'s Disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Alzheimer\'s Disease

8.3.1 Overview
8.3.2 Alzheimer\'s Disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Epilepsy

8.4.1 Overview
8.4.2 Epilepsy: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Essential Tremor

8.5.1 Overview
8.5.2 Essential Tremor: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.6 Depression

8.6.1 Overview
8.6.2 Depression: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.7 Dystonia

8.7.1 Overview
8.7.2 Dystonia: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.8 Amyotrophic Lateral Sclerosis

8.8.1 Overview
8.8.2 Amyotrophic Lateral Sclerosis: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

8.9 Neurofibromatosis 2

8.9.1 Overview
8.9.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Brain Implants Market Analysis – by End User

9.1 Hospitals and Specialized Clinics/Neurological Centers

9.1.1 Overview
9.1.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Brain Implants Market – North America Analysis

10.1 North America

10.1.1 North America Brain Implants Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Brain Implants Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Brain Implants Market Breakdown, by Treatment
10.1.1.1.2 US: North America Brain Implants Market Breakdown, by Application
10.1.1.1.3 US: North America Brain Implants Market Breakdown, by End User

10.1.1.2 Canada: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Brain Implants Market Breakdown, by Treatment
10.1.1.2.2 Canada: North America Brain Implants Market Breakdown, by Application
10.1.1.2.3 Canada: North America Brain Implants Market Breakdown, by End User

10.1.1.3 Mexico : North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Brain Implants Market Breakdown, by Treatment
10.1.1.3.2 Mexico : North America Brain Implants Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Brain Implants Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Brain Implants Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Blackrock Microsystems Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Boston Scientific Corp

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BrainGate

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Fisher Wallace Laboratories Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Functional Neuromodulation Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Medtronic Plc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Neuralink Corp

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 NeuroPace Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 NeuroSky Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Neurospine LLC

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 ONWARD Medical NV

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

13.13 Paradromics Inc

13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments

13.14 Renishaw Plc

13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments

13.15 Synchron Inc

13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments

14. Appendix

14.1 About Business Market Insights